LAPTM4B and cancer: Recently, it was found that LAPTM4B can bind to EGFR, and subsequently enhance and prolong the EGFR signaling [16] and initiate autophagy through a non-canonical EGFR signaling pathway and trafficking [17], which both facilitate the functions of EGFR on promoting cancer cell survival and proliferation.